Skip to main content
DAVITA INC. logo

DAVITA INC. — Investor Relations & Filings

Ticker · DVA ISIN · US23918K1088 LEI · M2XHYMU3TZNEZURC6H66 US Human health and social work activities
Open in API
Filings indexed 2,061 across all filing types
Latest filing 2019-01-04 Director's Dealing
Country US United States of America
Listing US DVA

About DAVITA INC.

https://www.davita.com/

DaVita Inc. is a healthcare provider specializing in kidney care services. The company offers a range of treatments for patients with chronic kidney disease and end-stage kidney disease, primarily through a network of outpatient dialysis centers. Its core service is providing life-sustaining dialysis, including in-center hemodialysis and peritoneal dialysis. In addition to clinical treatments, DaVita provides integrated health care management and extensive patient support. This includes educational resources, tools, and dietary guidance to help individuals manage their kidney health throughout their entire disease journey. The company focuses on delivering holistic and equitable care to improve the quality of life for its patients.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2019-01-04 English
FORM 4
Director's Dealing
2019-01-04 English
FORM 4
Director's Dealing
2019-01-04 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content describes an amendment to an Equity Purchase Agreement related to a material definitive agreement and a material impairment charge. It includes details about the transaction, regulatory approvals, and financial impacts but does not contain comprehensive financial statements or detailed financial performance data typical of Annual Reports (10-K) or Interim Reports (IR). The document is primarily an announcement of a material contract amendment and related financial impact, fitting the category of a Regulatory Filing (RNS) rather than a full financial report or other specific categories like M&A filings or Capital Updates. The length (9600 characters) and detailed description confirm it is not a brief announcement or a certification but a substantive regulatory disclosure. Therefore, the best classification is Regulatory Filings (RNS).
2018-12-17 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 21, 2018, by DaVita Inc. It reports the entry into a material definitive agreement, specifically an amendment to the company's senior secured credit agreement. The content focuses on financing arrangements, including leverage ratio changes and sale permissions related to subsidiaries. There are no financial statements or comprehensive financial performance data presented, only a description of a financing amendment. The document length is 3772 characters, which is relatively short and typical for an 8-K filing announcing a financing update. Therefore, this document fits best under the category of Capital/Financing Update (CAP).
2018-11-26 English
SC 13D/A
Major Shareholding Notification
2018-11-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.